Clinical trial investigates gabapentin for alcohol use disorder

What The Study Did:

This randomized clinical trial investigated if gabapentin, a drug often used to treat nerve pain, would be useful in the treatment of patients with alcohol use disorder (problem drinking that becomes severe) and a history of alcohol withdrawal symptoms. As many as 30 million people in the U.S. meet criteria for alcohol use disorder, yet less than 1 million receive medication that may be beneficial.

Authors:

Raymond F. Anton, M.D., of the Medical University of South Carolina in Charleston, is the corresponding author.

To access the embargoed study:

Visit our For The Media website at this link

https:/

(doi:10.1001/jamainternmed.2020.0249)

Editor’s Note:

The article includes conflict of interest and funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

###

Media advisory:

The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article

This link will be live at the embargo time

https:/

030920